JIC
ABBV icon

Joel Isaacson & Co’s AbbVie ABBV Stock Holding History

Joel Isaacson & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
8,694
+501
+6% +$108K 0.06% 132
2026
Q1 		$1.78M Buy
8,193
+101
+1% +$22.4K 0.06% 145
2025
Q4 		$1.85M Buy
8,092
+879
+12% +$200K 0.06% 136
2025
Q3 		$1.67M Buy
7,213
+440
+6% +$89.6K 0.06% 135
2025
Q2 		$1.26M Buy
6,773
+79
+1% +$14.7K 0.05% 146
2025
Q1 		$1.4M Buy
6,694
+497
+8% +$96.6K 0.06% 128
2024
Q4 		$1.1M Buy
6,197
+16
+0.3% +$2.94K 0.05% 141
2024
Q3 		$1.22M Sell
6,181
-97
-2% -$18.1K 0.06% 127
2024
Q2 		$1.08M Sell
6,278
-337
-5% -$55.8K 0.06% 126
2024
Q1 		$1.2M Sell
6,615
-75
-1% -$12.9K 0.07% 119
2023
Q4 		$1.04M Buy
6,690
+220
+3% +$32.1K 0.06% 124
2023
Q3 		$964K Buy
6,470
+3
+0% +$440 0.07% 120
2023
Q2 		$871K Sell
6,467
-97
-1% -$14.2K 0.06% 131
2023
Q1 		$1.05M Sell
6,564
-45
-0.7% -$6.88K 0.08% 115
2022
Q4 		$1.07M Sell
6,609
-530
-7% -$81.3K 0.08% 103
2022
Q3 		$958K Buy
7,139
+408
+6% +$58.5K 0.08% 108
2022
Q2 		$1.03M Buy
6,731
+390
+6% +$59.6K 0.09% 97
2022
Q1 		$1.01M Buy
6,341
+165
+3% +$24K 0.07% 110
2021
Q4 		$836K Sell
6,176
-2
-0% -$236 0.06% 136
2021
Q3 		$666K Buy
6,178
+69
+1% +$7.88K 0.05% 154
2021
Q2 		$688K Sell
6,109
-512
-8% -$57.7K 0.05% 143
2021
Q1 		$717K Hold
6,621
– – 0.06% 121
2020
Q4 		$709K Buy
6,621
+66
+1% +$6.34K 0.07% 115
2020
Q3 		$574K Buy
6,555
+108
+2% +$10.2K 0.07% 113
2020
Q2 		$633K Buy
6,447
+424
+7% +$37.3K 0.09% 101
2020
Q1 		$459K Buy
6,023
+640
+12% +$54.5K 0.08% 111
2019
Q4 		$477K Buy
5,383
+500
+10% +$41.5K 0.06% 131
2019
Q3 		$370K Buy
4,883
+361
+8% +$24.8K 0.05% 146
2019
Q2 		$329K Sell
4,522
-817
-15% -$64.2K 0.05% 155
2019
Q1 		$430K Buy
5,339
+250
+5% +$20.5K 0.06% 149
2018
Q4 		$449K Buy
5,089
+663
+15% +$58.3K 0.07% 142
2018
Q3 		$419K Hold
4,426
– – 0.07% 140
2018
Q2 		$410K Buy
4,426
+500
+13% +$48.8K 0.07% 136
2018
Q1 		$372K Hold
3,926
– – 0.06% 139
2017
Q4 		$380K Sell
3,926
-100
-2% -$9.43K 0.07% 134
2017
Q3 		$358K Buy
4,026
+100
+3% +$7.61K 0.07% 134
2017
Q2 		$285K Sell
3,926
-155
-4% -$10.4K 0.05% 147
2017
Q1 		$266K Buy
4,081
+155
+4% +$9.74K 0.05% 146
2016
Q4 		$246K Hold
3,926
– – 0.05% 138
2016
Q3 		$248K Buy
3,926
+580
+17% +$37.5K 0.05% 145
2016
Q2 		$207K Sell
3,346
-1,046
-24% -$63.7K 0.04% 157
2016
Q1 		$251K Sell
4,392
-200
-4% -$11.1K 0.06% 150
2015
Q4 		$272K Sell
4,592
-837
-15% -$48.2K 0.07% 133
2015
Q3 		$295K Buy
5,429
+259
+5% +$16.9K 0.08% 115
2015
Q2 		$347K Buy
5,170
+593
+13% +$38.7K 0.09% 112
2015
Q1 		$268K Buy
4,577
+5
+0.1% +$302 0.07% 132
2014
Q4 		$299K Buy
4,572
+1
+0% +$63 0.08% 113
2014
Q3 		$264K Buy
4,571
+200
+5% +$11.1K 0.08% 102
2014
Q2 		$247K Buy
4,371
+1
+0% +$52 0.08% 107
2014
Q1 		$225K Buy
4,370
+187
+4% +$9.45K 0.08% 109
2013
Q4 		$221K Hold
4,183
– – 0.08% 102
2013
Q3 		$187K Buy
4,183
+2,074
+98% +$91.9K 0.08% 111
2013
Q2 		$87K Buy
+2,109
New +$92.2K 0.04% 158

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Joel Isaacson & Co's ABBV Position: Q2 2026 in Review

Joel Isaacson & Co increased its AbbVie (ABBV) stake by 6.1% in Q2 2026, buying an estimated $108K and bringing the position to 8,694 shares worth $2.19M. The position accounts for 0.06% of the portfolio, ranked #132.

Joel Isaacson & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Joel Isaacson & Co held 8,694 shares of AbbVie worth $2.19M as of Q2 2026.
  • Joel Isaacson & Co bought 501 AbbVie shares in Q2 2026, an estimated $108K.
  • AbbVie made up 0.06% of Joel Isaacson & Co's portfolio in Q2 2026, its #132 holding.
  • Joel Isaacson & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.